Nepodin

Pharmacology & Research

Nepodin (musizin) is the characteristic naphthalene derivative of dock (Rumex) roots — and the headline accuracy point is that it is not what makes yellow dock a laxative. Yellow dock’s stimulant-laxative and renal cautions belong to its anthraquinones (emodin, chrysophanol, physcion, rhein) and oxalates; nepodin is a structurally distinct 2-acetyl-1,8-dihydroxy-3-methylnaphthalene with no laxative role. Its own evidence is genuinely thin — three primary studies, one per signal — unified loosely by a mitochondrial/AMPK-axis theme. There are no human trials.

1. Antidiabetic / metabolic

Nepodin’s distinctive and most coherent signal: it activates AMPK in L6 myotubes and increases GLUT4 translocation to drive skeletal-muscle glucose uptake — acting as a direct AMPK/mitochondrial-function stimulator rather than through insulin secretion — and lowered fasting glucose and improved glucose tolerance in db/db mice ^{1Reference 1Ha BG et al. · 2014In vitroAntidiabetic effect of nepodin, a component of Rumex roots, and its modes of action in vitro and in vivoView study →}.

Gap: a single primary study in one rodent model, isolated-constituent only, with no dose-response translation, no independent replication and no human data ^{1Reference 1Ha BG et al. · 2014In vitroAntidiabetic effect of nepodin, a component of Rumex roots, and its modes of action in vitro and in vivoView study →}.

2. Antimalarial

Nepodin isolated from Rumex crispus inhibited Plasmodium falciparum PfNDH2 (a parasite type-II NADH dehydrogenase) at low-µg/mL IC50 against chloroquine-sensitive and -resistant strains, with high parasitaemia suppression in mice ^{2Reference 2Lee JH et al. · 2013Antimalarial activity of nepodin isolated from Rumex crispusView study →} — mechanistically consistent with the mitochondrial/AMPK theme.

Gap: a single study with no follow-up and no selectivity/therapeutic-index characterisation versus host mitochondrial enzymes, purely preclinical ^{2Reference 2Lee JH et al. · 2013Antimalarial activity of nepodin isolated from Rumex crispusView study →}.

3. Antifungal / antibiofilm

Nepodin (from Rumex japonicus) suppressed Candida albicans hyphal growth and biofilm — including dual-species biofilms — while sparing planktonic growth, an anti-virulence rather than biocidal profile ^{3Reference 3Lee JH et al. · 2019Inhibition of biofilm formation by Candida albicans and polymicrobial microorganisms by nepodin via hyphal-growth suppressionView study →}.

Gap: R. japonicus material (a genus-level caveat), a single study, with no in-vivo confirmation and an anti-biofilm (not fungicidal) effect ^{3Reference 3Lee JH et al. · 2019Inhibition of biofilm formation by Candida albicans and polymicrobial microorganisms by nepodin via hyphal-growth suppressionView study →}.

Mechanisms

Target / pathway	Effect	Relevant to
AMPK (activation)	phosphorylates/activates AMPK in muscle cells	antidiabetic / metabolic
GLUT4 translocation	increased → skeletal-muscle glucose uptake	antidiabetic / metabolic
Mitochondrial function (skeletal muscle)	stimulated, consistent with AMPK engagement	antidiabetic / metabolic
PfNDH2 (parasite type-II NADH dehydrogenase)	inhibited → blocked mitochondrial electron transport	antimalarial
C. albicans hyphal transition / biofilm	suppressed; spares planktonic cells	antifungal / antibiofilm

The recurring theme is mitochondrial/AMPK-axis modulation, which plausibly unifies the antidiabetic and antimalarial signals.

Pharmacokinetics

No dedicated pharmacokinetic study of nepodin exists. As a small lipophilic naphthalene derivative, its ADME is essentially uncharacterised — no human or animal absorption, metabolism or half-life data. The rodent efficacy studies establish only that systemic exposure sufficient for effect is achievable in mice ^{1,2Reference 1Ha BG et al. · 2014In vitroAntidiabetic effect of nepodin, a component of Rumex roots, and its modes of action in vitro and in vivoView study →Reference 2Lee JH et al. · 2013Antimalarial activity of nepodin isolated from Rumex crispusView study →}, not quantitative pharmacokinetics — so in-vitro potencies should be read as un-discounted by bioavailability.

Clinical trials

There are no human trials of isolated nepodin/musizin; all evidence is in-vitro and rodent. Any human exposure is incidental, via whole yellow-dock/Rumex preparations where nepodin is a minor constituent and the dominant pharmacology belongs to other molecules.

Last checked: July 2026.

Toxicity & Safety

Nepodin’s [low] flag applies at the levels studied, with an honest caveat. No dedicated toxicology exists; in the antimalarial study, mouse doses up to 250 mg/kg produced efficacy without a reported acute-toxicity signal ^{2Reference 2Lee JH et al. · 2013Antimalarial activity of nepodin isolated from Rumex crispusView study →}, and the antidiabetic db/db study dosed without a flagged concern ^{1Reference 1Ha BG et al. · 2014In vitroAntidiabetic effect of nepodin, a component of Rumex roots, and its modes of action in vitro and in vivoView study →}. The parent-class hazard does not transfer automatically — unsubstituted naphthalene is haemolytic/carcinogenic, but nepodin is a heavily oxygenated, substituted naphthalene, a distinct molecule; still, there are no genotoxicity or chronic-toxicity data to affirmatively clear it, which is why the rating is [low] at studied levels rather than an unqualified clean bill. Critically, keep it distinct from yellow dock’s own cautions: the oxalate/renal load and anthraquinone stimulant-laxative effects are not nepodin’s and should not be imported onto this page.

Pregnancy & lactation

Avoid / insufficient data. There is no reproductive or developmental toxicology for nepodin and no human exposure data, so it should be treated as contraindicated in pregnancy and lactation on the standard “no data + bioactive isolate” basis. (Separately, whole yellow dock is itself cautioned in pregnancy for its anthraquinone/oxalate content — a different rationale.)

Dosage

There is no established or safe human dose — nepodin is not sold or used as an isolated supplement and has no human dosing. Research doses are for context only: antimalarial mouse studies used ~10–250 mg/kg ^{2Reference 2Lee JH et al. · 2013Antimalarial activity of nepodin isolated from Rumex crispusView study →}, the antidiabetic db/db study used effective oral dosing ^{1Reference 1Ha BG et al. · 2014In vitroAntidiabetic effect of nepodin, a component of Rumex roots, and its modes of action in vitro and in vivoView study →}, and in-vitro antifungal/antimalarial effects fell in the sub-µg/mL to low-µg/mL range ^{2,3Reference 2Lee JH et al. · 2013Antimalarial activity of nepodin isolated from Rumex crispusView study →Reference 3Lee JH et al. · 2019Inhibition of biofilm formation by Candida albicans and polymicrobial microorganisms by nepodin via hyphal-growth suppressionView study →} — none of which is a recommendation.

References

1. Ha BG, et al. (2014). Antidiabetic effect of nepodin, a component of Rumex roots, and its modes of action in vitro and in vivo. BioFactors. https://pubmed.ncbi.nlm.nih.gov/24756979/
2. Lee JH, et al. (2013). Antimalarial activity of nepodin isolated from Rumex crispus. Archives of Pharmacal Research. https://pubmed.ncbi.nlm.nih.gov/23440579/
3. Lee JH, et al. (2019). Inhibition of biofilm formation by Candida albicans and polymicrobial microorganisms by nepodin via hyphal-growth suppression. ACS Infectious Diseases. https://pubmed.ncbi.nlm.nih.gov/31055910/